sample	tissue	condition	fpkm
SRR516124	skin	male and 3.5 year	13.0436
SRR516123	skin	male and 3.5 year	3.7145699999999997
SRR516121	skin	male and 3.5 year	2.15292
SRR1205160	5dpf	transgenic sqET20 and GFP+	1.9058700000000002
SRR516125	skin	male and 3.5 year	1.7850099999999998
SRR801556	embryo	RPS19 and p53 morpholino	1.02629
SRR941749	anterior pectoral fin	normal	0.855025
SRR516129	skin	male and 5 month	0.6682600000000001
SRR1004787	larvae	impdh1a morpholino	0.47738
SRR1205157	5dpf	transgenic sqET20 and neomycin treated 1h and GFP+	0.417867
SRR1188148	embryo	Control PBS 0.5 hpi	0.380805
SRR1035978	13 hpf	rx3-/-	0.363172
SRR1188152	embryo	Insulin 0.5 hpi	0.346983
SRR514030	retina	id2a morpholino	0.344549
SRR519732	7 dpf	FETOH treatment	0.323995
SRR1205154	5dpf	transgenic sqET20	0.28136500000000003
SRR1565817	brain	normal	0.232805
SRR1035981	13 hpf	rx3+/+ or rx3+/-	0.22479200000000002
SRR941753	posterior pectoral fin	normal	0.20988800000000002
SRR630464	5 dpf	injected epidermidis	0.20636300000000002
SRR519742	4 dpf	VD3 treatment	0.17235599999999998
SRR1205169	5dpf	transgenic sqET20 and neomycin treated 5h and GFP+	0.169323
SRR1104059	heart	kctd10 mut	0.14299
SRR519717	2 dpf	FETOH treatment	0.11168399999999999
SRR519747	6 dpf	VD3 treatment	0.078278
SRR519737	2 dpf	VD3 treatment	0.0630663
SRR519752	7 dpf	VD3 treatment	0.05251619999999999
SRR519722	4 dpf	FETOH treatment	0.0382815
SRR519727	6 dpf	FETOH treatment	0.0201025